Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity

Food reward, hyperphagia, and obesity

(2011) Hans-Rudolf Berthoud et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Amygdala circuitry mediating reversible and bidirectional control of anxiety

(2011) Kay M. Tye et al.   NATURE

Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety

(2011) Larry S Zweifel et al.   NATURE NEUROSCIENCE

Personalized medicine can pave the way for the safe use of CB1 receptor antagonists

(2011) Judit Lazary et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Localization of Dysfunction in Major Depressive Disorder: Prefrontal Cortex and Amygdala

(2010) Elisabeth A. Murray et al.   BIOLOGICAL PSYCHIATRY

Pharmacological management of appetite expression in obesity

(2010) Jason C. G. Halford et al.   Nature Reviews Endocrinology

Reconsidering anhedonia in depression: Lessons from translational neuroscience

(2010) Michael T. Treadway et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142

(2009) K.S. Sink et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation

(2009) V Di Marzo et al.   INTERNATIONAL JOURNAL OF OBESITY

A Role for the Endocannabinoid System in the Increased Motivation for Cocaine in Extended-Access Conditions

(2009) L. Orio et al.   JOURNAL OF NEUROSCIENCE

Prosocial Effects of Nicotine and Ethanol in Adolescent Rats Through Partially Dissociable Neurobehavioral Mechanisms

(2009) Viviana Trezza et al.   NEUROPSYCHOPHARMACOLOGY

The future of endocannabinoid-oriented clinical research after CB1 antagonists

(2009) Bernard Le Foll et al.   PSYCHOPHARMACOLOGY

Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease

(2008) Steven E. Nissen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Hope and Fear of Rimonabant

(2008) John S. Rumsfeld   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Constitutive Activity of the Cannabinoid CB1 Receptor Regulates the Function of Co-expressed Mu Opioid Receptors

(2008) Meritxell Canals et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Presynaptic metabotropic glutamate receptors regulate glutamatergic input to dopamine neurons in the ventral tegmental area

(2008) M. de Rover et al.   NEUROSCIENCE

Feeding Induced by Cannabinoids Is Mediated Independently of the Melanocortin System

(2008) Puspha Sinnayah et al.   PLoS One

Anti-obesity drugs and neural circuits of feeding

(2008) R ADAN et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area

(2007) Ferenc Mátyás et al.   NEUROPHARMACOLOGY